Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis is expected to experience strong financial growth in the coming years, driven by its initiatives to reach $1 billion in revenue by 2025 and $1.5 billion in revenue by 2026. Although the company's balance sheet remains highly leveraged, the potential for further monetization of fuel and tax credits, improvements in ethanol economics, and progress on key projects such as the India plant and biogas facilities provide upside opportunities for investors. These factors, along with the recent Q1 revenue growth and attractive valuation, lead to a positive outlook for Aemetis. However, risks such as balance sheet and liquidity concerns, political and regulatory challenges, and changing market factors should also be considered.

Bears say

Aemetis is currently facing near-term challenges in terms of losses and tight liquidity. However, potential approval for expanded fuel usage, digester RNG pathway approval, and upcoming catalysts may all drive the stock in the long term. Despite these potential positives, there are still risks to consider such as political and regulatory changes, commodity and crude oil prices, and changes in consumer demand for alternative energy.

Aemetis (AMTX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.